UPDATE : Tuesday, July 23, 2019
상단여백
Yuhan invests ₩6 billion in Imnewrun Biosciences
Yuhan Corp. said it has invested 6 billion won ($5.09 million) in Imnewrun ...
by Lee Han-soo  |  2019-07-08 12:05
라인
Vuno's dementia diagnosis medical device wins certification
Vuno said that "VUNO Med – DeepBrain," a dementia diagnosis medical d...
by Lee Han-soo  |  2019-07-05 17:43
라인
Dong-A ST, Dongwha Pharm lose status of innovative drugmaker
Dong-A ST and Dongwha Pharm failed to renew the state-designated certificat...
by Jeong Sae-im  |  2019-07-05 16:00
라인
Lilly aims to reshape Korea’s breast cancer treatment market
Lilly Korea is seeking to reshape Korea’s breast cancer treatment market on...
by Lee Han-soo  |  2019-07-05 16:00
라인
Victims question Kolon CEO’s sincerity in apology
Oh Kims Law & Co., leading a lawsuit against Kolon Life Science on behalf o...
by Jeong Sae-im  |  2019-07-05 15:14
라인
‘Laparoscopic gastric surgery safe, effective for advanced gastric cancer patients’
A study has found that laparoscopic surgery, which is known to have an adva...
by Lee Han-soo  |  2019-07-05 14:53
라인
[Special] Physician pushes to create global network for ‘dialysis trips'
For end-stage renal disease (ESRD) patients, traveling overseas is a challe...
by Song Soo-youn  |  2019-07-05 14:53
라인
Samsung, Genentech settle patent dispute on Herceptin biosimilar
Samsung Bioepis has settled a patent infringement case with Genentech, a su...
by Lee Han-soo  |  2019-07-05 11:47
라인
'Rehabilitation treatment is effective for cancer patients'
Local researchers have found that rehabilitation therapy for patients with ...
by Lee Han-soo  |  2019-07-04 17:14
라인
[Special] End-stage renal disease patients regain joy of travel in Korea
More than 20 Taiwanese tourists visited Beomil Yonsei Internal Medicine Cli...
by Song Soo-youn  |  2019-07-04 15:37
라인
SNUH closer to developing cell-gene therapy to regenerate heart muscle
Researchers at Seoul National University Hospital have found evidence to de...
by Lee Han-soo  |  2019-07-04 15:33
라인
Kolon confident to resume US trial on Invossa
The government has decided to nullify Invossa-K’s license effective next Tu...
by Lee Hye-seon  |  2019-07-04 14:05
라인
China OKs Alteogen’s Herceptin biosimilar for clinical trials
Alteogen said that Qilu Pharmaceutical, its Chinese partner, has received i...
by Lee Han-soo  |  2019-07-04 14:04
라인
‘Truvada will improve Korea's HIV treatment environment’
Gilead Science is strengthening its position in the local human immunodefic...
by Lee Han-soo  |  2019-07-04 10:53
라인
Janssen nixes deal with Hanmi over antidiabetic obesity drug
Janssen, a subsidiary of Johnson & Johnson, has decided to return the devel...
by Jeong Sae-im  |  2019-07-04 10:52
라인
Rheumatoid arthritis treatment can improve Alzheimer symptoms
A local research has found that Humira, Abbvie's rheumatoid arthritis d...
by Lee Han-soo  |  2019-07-03 18:01
라인
‘Psoriasis patients have redoubled risk of suffering from mental illness’
A research team at St. Mary’s hospital has found that patients who have pso...
by Lee Han-soo  |  2019-07-03 16:18
라인
‘State lung cancer screening will raise false positive diagnoses’
The government has decided to add lung cancer to the state cancer screening...
by Kim Eun-young  |  2019-07-03 15:38
라인
Bukwang, UK university to co-develop Parkinson’s disease treatment
Bukwang Pharmaceutical has signed a multibillion-won contract with Universi...
by Lee Han-soo  |  2019-07-03 15:03
라인
Myongji Hospital celebrates 10 years of innovation and change
Myongji Hospital has done all it could to change and innovate the hospital’...
by Lee Han-soo  |  2019-07-03 13:31
여백
여백
여백
Back to Top